BioSeeker Cancer Highlights™ Publications

A Decision Support Tool for Optimizing the Cancer Pipeline Portfolio. From Research and Development to Market.

Cancer Highlights™ is BioSeeker Group’s flagship decision support tool, for portfolio assessment and planning of cancer drug development.

Drug development is not what it used to be. Gone are the days of relying on blockbusters. Instead, the drug industry is faced with identifying incremental drug improvements towards personalized medicine that will be commercially compelling. Tremendous opportunities in the field of personalized medicine are the new horizon.

Cancer Highlights™ is written for you to understand and assess the impact of competitors and the corresponding changes to development strategies in oncology for your own portfolio products. It helps business teams to maximize molecule value by selecting optimal development plans and managing risk and uncertainty.

Watch our Cancer Highlights™ Presentation Video

Drug target strategies are the critical link between drugs and their role in the treatment of medical disorders. Cancer Highlights™ applies systems to attain robust analytical and strategic insight to support both internally to pipeline and portfolio planning and to stakeholders across your own organization. It will also be an important part of creating and implementing a market development plan for cancer drugs to ensure that the optimal market conditions exist by the time the product is commercialized.

We deliver these insights to you through our Cancer Focus Areas.

Cancer Focus Areas

The Cancer Highlights™ publication range examines 14 different, high impact Cancer Focus Areas, divided into the three main classes of Tumor Type, Mechanism/Target/Effect and Compound Strategy.

Cancer Highlights’™ Five Pillar Assessment

Cancer Highlights™ uses standardized criteria in a five pillar assessment to compare drug development strategies in oncology, making it easy to find and compare analysis not only within one single Cancer Focus Area but also between different areas.
These five pillars are:

• I - Considering the Therapeutic Target
• II - Emerging New Products to Established Ones
• III - Compound Strategies at Work
• IV - Selecting Cancer Indications
• V - Pipeline & Portfolio Planning

Click here to request more information and free sample pages from the Cancer Highlights series.

Subscribe Today and Start Saving

We at BioSeeker would like to invite you to maximize your commercial insights in oncology to an optimized budget. Our competitively priced Cancer Highlights™ is an attractive investment for many companies, from big pharma to emerging biotechnology companies. You will save 65-75% compared to a normal single copy price.

A subscription consists of eight (8) consecutive reports from a rolling update of 14 different Cancer Focus Areas. Your subscription will commence with the latest report available and automatically end after eight (8) publications and you will be notified about making a renewal. BioSeeker publishes new reports every six weeks and these will be immediately delivered to your inbox in PDF format.


Click here to start your Cancer Highlights Subscription

Key Benefits

Cancer Highlights™ serves as an external commercial advocate for pharmaceutical companies’ pipeline and portfolio planning in oncology by:

• Providing you with competitive input to the R&D organization to guide development of early product ideas and ensure efforts are aligned with business objectives
• Assisting you to make informed decisions in selecting cancer indications that are known to be appropriate for your drug’s properties
• Analyzing, correlating and integrating valuable data sources in order to provide accurate data for valuation of pipeline, in-licensing and new business opportunities
• Providing you with commercial analytic support for due diligence on in-licensing and acquisition opportunities
• Supporting development of integrative molecule, pathway and disease area strategies
• Integrating knowledge to help you to consider the therapeutic target for the highest therapeutic outcome and return on investment

Available Cancer Highlights Reports

When you purchase a single issue of Cancer Highlights, you may subtract your first investment from the subscription price when you upgrade to a subscription, within a month from the date of purchase.

List of reports...